MM-133: HORIZON (OP-106): Melflufen Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma (RRMM) Refractory to Pomalidomide and/or an Anti-CD38 Monoclonal Antibody (mAb) – Final Primary Analysis

Paul G. Richardson, María‐Victoria Mateos, Alessandra Larocca et al.|Clinical Lymphoma Myeloma & Leukemia|2020

Cited by 0